JP7535040B2 - 歩行能力改善剤 - Google Patents

歩行能力改善剤 Download PDF

Info

Publication number
JP7535040B2
JP7535040B2 JP2021524835A JP2021524835A JP7535040B2 JP 7535040 B2 JP7535040 B2 JP 7535040B2 JP 2021524835 A JP2021524835 A JP 2021524835A JP 2021524835 A JP2021524835 A JP 2021524835A JP 7535040 B2 JP7535040 B2 JP 7535040B2
Authority
JP
Japan
Prior art keywords
lactic acid
acid bacteria
health
improving
food
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021524835A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020246430A1 (https=
Inventor
慎治 坂田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Group Holdings Ltd
Original Assignee
Asahi Group Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Group Holdings Ltd filed Critical Asahi Group Holdings Ltd
Publication of JPWO2020246430A1 publication Critical patent/JPWO2020246430A1/ja
Application granted granted Critical
Publication of JP7535040B2 publication Critical patent/JP7535040B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
JP2021524835A 2019-06-03 2020-06-01 歩行能力改善剤 Active JP7535040B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019103777 2019-06-03
JP2019103777 2019-06-03
PCT/JP2020/021637 WO2020246430A1 (ja) 2019-06-03 2020-06-01 歩行能力改善剤

Publications (2)

Publication Number Publication Date
JPWO2020246430A1 JPWO2020246430A1 (https=) 2020-12-10
JP7535040B2 true JP7535040B2 (ja) 2024-08-15

Family

ID=73652555

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021524835A Active JP7535040B2 (ja) 2019-06-03 2020-06-01 歩行能力改善剤

Country Status (5)

Country Link
US (1) US20220233613A1 (https=)
EP (1) EP3978075A4 (https=)
JP (1) JP7535040B2 (https=)
AU (1) AU2020289102B2 (https=)
WO (1) WO2020246430A1 (https=)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010155790A (ja) 2008-12-26 2010-07-15 Yakult Honsha Co Ltd 麦汁発酵物及びその利用
WO2012133533A1 (ja) 2011-03-31 2012-10-04 大塚製薬株式会社 Ｑｏｌ改善又は持続剤
JP2013047192A (ja) 2011-08-29 2013-03-07 Meiji Co Ltd 身体活動を促進させる乳酸菌
WO2014132982A1 (ja) 2013-02-27 2014-09-04 株式会社明治 ストレス軽減剤
JP2016216408A (ja) 2015-05-22 2016-12-22 アサヒグループホールディングス株式会社 筋肉の分解抑制剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100996577B1 (ko) * 2009-04-01 2010-11-24 주식회사한국야쿠르트 혈중 콜레스테롤 강하와 비만 억제 효능을 갖는 신규의 락토바실러스 커베터스 에이취와이7601 및 이를 유효성분으로 함유하는 제품
MY160992A (en) * 2010-11-09 2017-03-31 Asahi Group Holdings Ltd Lactobacillus helveticus having high proteolysis activity
WO2018003900A1 (ja) * 2016-06-30 2018-01-04 アサヒグループホールディングス株式会社 栄養状態改善に使用するための組成物
KR20180019474A (ko) * 2016-08-16 2018-02-26 주식회사 엠디헬스케어 락토바실러스 플란타룸 유래 소포를 포함하는 정신질환 예방 또는 치료용 조성물
WO2018073963A1 (ja) * 2016-10-21 2018-04-26 森永乳業株式会社 気分プロフィール改善剤
JP7118344B2 (ja) 2017-05-26 2022-08-16 日環科学株式会社 筋肉改質剤
JP6469292B1 (ja) 2017-12-14 2019-02-13 アリスビジョン株式会社 観察画像を立体視させる歯科用３ｄデジタル顕微鏡システム及び歯科用ディスプレイ支持機構

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010155790A (ja) 2008-12-26 2010-07-15 Yakult Honsha Co Ltd 麦汁発酵物及びその利用
WO2012133533A1 (ja) 2011-03-31 2012-10-04 大塚製薬株式会社 Ｑｏｌ改善又は持続剤
JP2013047192A (ja) 2011-08-29 2013-03-07 Meiji Co Ltd 身体活動を促進させる乳酸菌
WO2014132982A1 (ja) 2013-02-27 2014-09-04 株式会社明治 ストレス軽減剤
JP2016216408A (ja) 2015-05-22 2016-12-22 アサヒグループホールディングス株式会社 筋肉の分解抑制剤

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
YAMAMURA, S., et al.，Eur. J. Clin. Nutr.，2009年，vol.63, issue 1，p.100-105
日本内科学会雑誌，vol.107, no.9，2018年，p.1697-1701

Also Published As

Publication number Publication date
EP3978075A1 (en) 2022-04-06
WO2020246430A1 (ja) 2020-12-10
JPWO2020246430A1 (https=) 2020-12-10
EP3978075A4 (en) 2023-07-12
AU2020289102B2 (en) 2025-07-03
US20220233613A1 (en) 2022-07-28
AU2020289102A1 (en) 2022-01-20

Similar Documents

Publication Publication Date Title
KR101638984B1 (ko) 나노형 김치 유산균
CN103764155B (zh) 促进身体活动的乳酸菌
JP6261688B2 (ja) Ｑｏｌ改善又は持続剤
CN111212575A (zh) 肌肉增量用组合物
JP5943342B2 (ja) 概日リズム改善剤
JP5945092B2 (ja) 中性脂肪低減剤
KR102789055B1 (ko) 장내 미생물 또는 이로부터 유래된 세포밖 소포체를 유효성분으로 포함하는 수면장애의 예방, 개선 또는 치료용 조성물
JP7535040B2 (ja) 歩行能力改善剤
JP6904670B2 (ja) 下痢型過敏性腸症候群抑制剤及び食品組成物
CN115803039A (zh) 认知功能改善剂、认知功能维持剂、海马体功能改善剂和海马体功能维持剂
EP4527919A1 (en) Prevotella histicola
US20240335488A1 (en) Novel lactobacillus helveticus ua881 strain and probiotic composition for improving intestinal permeability and metabolic disorders
JP7663240B2 (ja) 腸管免疫賦活剤及びＩｇＡ産生促進剤
JP2025072341A (ja) 月経随伴症状の処置のための組成物
KR20230160115A (ko) 프레보텔라 히스티콜라 kcom 4081
KR20230160117A (ko) 프레보텔라 히스티콜라 kcom 4227
KR20230160116A (ko) 프레보텔라 히스티콜라 kcom 3796
JP2025026441A (ja) グレリン分泌促進用組成物
JP5815105B2 (ja) 中性脂肪低減剤
JP2022060541A (ja) 下痢型過敏性腸症候群抑制剤及び食品組成物
JP2006335721A (ja) 肩こり改善組成物、及びそれを含有する飲食品、医薬部外品、医薬品
WO2024029620A1 (ja) 脳血流量増加剤、脳活動促進剤及び覚醒度向上剤
TW202428292A (zh) 用以維持口腔內環境或牙齦之健康之組合物
KR20240118625A (ko) 락티플란티바실러스 플란타럼 y7 균주를 포함하는 수면 질 개선용 조성물
CN111297912A (zh) 胚芽乳酸杆菌twk10制备抗运动后发炎或降体脂组合物的用途

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20221206

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20231031

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20231227

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240207

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240423

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240520

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240730

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240802

R150 Certificate of patent or registration of utility model

Ref document number: 7535040

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150